ICMR fast-tracks approvals for Israeli COVID-19 research coo
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
The government has pulled all stops to help Israel conduct COVID-19 research on patients admitted to four Delhi hospitals, including transfer of saliva samples and patients’ data to Israel, The Hindu has learnt.

The Defence Research and Development Organisation (DRDO) is collaborating with Israel’s Directorate of Defense Research and Development (DRDD) to conduct trials on Indian patients that include an audio test, a breath test, thermal testing and a polyamino test to isolate proteins related to COVID-19.

The trial obtained “expedited approval” by the Health Ministry’s Screening Committee (HSMC) on July 28. The decision is yet to be endorsed by the full committee that is expected to meet in August.

Though the ICMR is the apex body for biomedical research and foreign-aided research in the country, the current trials will be controlled by the DRDO.

DRDO proposes to transfer 5,000 saliva samples to the Israeli defence team.

Patient samples are being collected at Lady Hardinge Medical College and Hospital and Ram Manohar Lohia Hospital, Sir Gangaram Hospital and Lok Nayak Jaiprakash Hospital (LNJP).

While approving the trial on June 28, the ICMR chief expressed caution on handling of the saliva samples of COVID-19 patients as it may contain live virus.

Delhi Government has also waived the mandatory seven-day quarantine period for the 35-member Israeli team.

The statement said the trial of four different kinds of technologies that have the potential to detect coronavirus in as less as 30 seconds have started.

Source: https://www.thehindu.com/sci-tech/health/icmr-fast-tracks-approvals-for-israeli-research-coordinated-by-drdo/article32248603.ece
K●●●●●●h P●●●l and 8 others like this1 share